510(k) Is OK For Spinal Cage Devices Following FDA Downclassification
This article was originally published in The Gray Sheet
Executive Summary
Conventional spinal fusion cage devices will require only 510(k) clearance rather than more rigorous PMA approval to enter the U.S. market starting July 12
You may also be interested in...
Stryker Spine Putty Approval “Significantly” Delayed, Firm Says
FDA is requesting additional data to support Stryker's OP-1 Putty PMA, which could delay approval of the posterolateral lumbar spine fusion surgery indication until 2009, the firm says
Spinal Cage Downclassification Endorsed; Long-Term Data Need Highlighted
FDA's Orthopedic & Rehabilitation Devices Panel recommendations emphasize a need for long-term data collection from intervertebral body fusion devices, in the event that the products are downclassified
Darzalex Surpasses Stelara As J&J’s Best-Selling Drug
Sales of Stelara are expected to begin tapering off later this year when the first biosimilars launch in mid-2024 in Europe and later in the US.